NFE2L2 and diabetic kidney disease: In DKD mice and HG-induced HK-2 cells, empagliflozin activated AMPK/Nrf2, upregulating GPX4, SLC7A11, and FTH1, thereby inhibiting ferroptosis and protecting HK-2 cells.